What is not typically true for choledochal cysts, which are congenital (present at birth) cystic dilations of the intrahepatic and/or extrahepatic biliary tree (bile ducts)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Characteristics of Choledochal Cysts

The incorrect statement about choledochal cysts is that the incidence is 1:1,000 (option A), as the actual prevalence varies from 1:100,000 in Western countries to 1:13,000 in Japan. 1, 2

Epidemiology of Choledochal Cysts

  • Choledochal cysts have a reported prevalence ranging from 1:100,000 in Western populations to significantly higher rates (1:13,000) in Asian countries, particularly Japan 1, 2
  • They occur 3-8 times more frequently in females than males, making option C (3-8x more common in females than males) a correct statement 3
  • The condition is considered rare in Western countries, which contributes to potential diagnostic delays 3

Pathophysiology and Definition

  • Choledochal cysts are indeed congenital cystic dilations of the intrahepatic and/or extrahepatic biliary tree, making option D a correct statement 1, 4
  • Over 90% of patients with choledochal cysts have an anomalous pancreaticobiliary duct junction, with the pancreatic duct joining the common bile duct >1 cm proximal to the ampulla, confirming option B as correct 3
  • This anomalous junction allows pancreatic enzymes to reflux into the biliary system, contributing to inflammation, biliary epithelial damage, and increased risk of malignancy 3

Clinical Significance and Management

  • Choledochal cysts are associated with a significantly increased risk of developing cholangiocarcinoma if left untreated 4
  • The risk of malignant transformation (cholangiocarcinoma) is reported to be up to 30% in untreated cases 2
  • Complete excision of the choledochal cyst with Roux-en-Y hepaticojejunostomy is the treatment of choice to prevent malignant transformation 1, 4
  • Cases registered with the Japanese Study Group on Pancreaticobiliary Maljunction over a 10-year period indicated that the incidence of cholangiocarcinoma is 7.0% in cases of pancreaticobiliary maljunction with dilated bile ducts (choledochal cysts) 3

Classification and Types

  • Choledochal cysts are categorized according to the Todani classification based on location, shape, and multiplicity 1, 2
  • Type I (solitary, extrahepatic) and Type IV (intra- plus extrahepatic) bile duct cysts have the greatest predisposition to malignancy 1

Clinical Presentation and Diagnosis

  • Patients may present with jaundice (84-90%), weight loss (35%), abdominal pain (30%), nausea and vomiting (12-25%), and fever (10%) 3, 1
  • Many patients are asymptomatic and diagnosed incidentally 1
  • Contrast-enhanced MRI with magnetic resonance cholangiopancreatography (MRCP) is superior for accurate assessment of biliary obstruction 1

References

Guideline

Management of Choledochal Cysts

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Congenital Anomalies of the Hepatobiliary System

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Choledochal Cysts

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.